NEUROD1 and Alzheimer disease: Moreover, we confirmed a decrease in the number of Aβ plaques (Fig. 5m, n), coupled with an increase in the number of NeuroD1+ cells in the SCH772984-treated AD mouse hippocampus (Supplementary Fig. 16e, f).